IP Verse

Combination Therapy For The Treatment Of Ovarian Cancer - EP2825558B1

PatentPatent Analysis

EP2825558

FHOFFMANN LA ROCHE
Application Number
EP13708435A
Filing Date
Mar 11, 2013
Status
Granted And Under Opposition
Apr 12, 2019
Grant Date
May 15, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3083686B2
EP2582286B2
EP2926142B2

Bibliography

The patent EP2825558B1 was granted to Fhoffmann LA Roche on May 15, 2019 following the initial filing on Mar 11, 2013 under the application number EP13708435A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ZENTIVA PHARMAAug 28, 2024INTERVENTION ADMISSIBLE
AMGENFeb 17, 2020WITHDRAWN
CELLTRIONFeb 17, 2020WITHDRAWN
DR REDDYS LABORATORIESFeb 17, 2020WITHDRAWN
GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBFeb 17, 2020WITHDRAWN
DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBBFeb 14, 2020ADMISSIBLE
MABXIENCE RESEARCHFeb 14, 2020ADMISSIBLE
STADA ARZNEIMITTELFeb 14, 2020ADMISSIBLE
HOFFMANN EITLEFeb 14, 2020WITHDRAWN
POHLMANFeb 14, 2020WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents